XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive and Employee Stock Purchase Plan (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Valuation Assumptions of Market-based Restricted Stock Awards Granted
The Monte Carlo valuation model used to estimate the fair value of the market-based awards granted utilized the following weighted-average assumptions:
December 31, 2022December 31, 2021
Underlying stock price at valuation date$59.66 $57.06 
Expected volatility43.8 %35.1 %
Risk-free interest rate3.6 %1.3 %
Contractual term8 years6.1 years
The Monte Carlo valuation model used by the Former Parent to estimate the fair value of market-based restricted stock awards granted utilized the following weighted-average assumptions:
December 31,December 31,
20212020
Underlying stock price at valuation$113.27 $91.17 
Expected volatility30.3 %27.0 %
Risk-free interest rate1.3 %0.7 %
Contractual term8 years8 years
Restricted Stock Award Activity
Restricted stock activity for the years ended December 31, 2022 and 2021 is set forth below: 
Number of Shares
Weighted-Average
Grant-Date
Fair Value (1)
Nonvested at January 1, 2021— $— 
Exchanged in Separation65,235 38.46 
Granted— — 
Vested— — 
Canceled— — 
Nonvested at December 31, 202165,235 $38.46 
Granted884 37.67 
Vested(30,703)38.50 
Canceled— — 
Nonvested at December 31, 2022
35,416 $38.42 
(1) The Company revised the grant date fair value of certain awards which were inaccurately disclosed related to the prior period. The Company determined that the update of this disclosure did not have a material impact to the current or prior period financial statements.
The restricted stock award activity for the years ended December 31, 2021 and 2020 is set forth below:
SharesWeighted-Average Grant-Date Fair Value
Nonvested at January 1, 202037,674 $75.03 
Granted— — 
Vested(7,785)76.43
Canceled(3,020)77.37
Nonvested at December 31, 202026,869 $57.21 
Granted— — 
Vested(6,189)74.52 
Canceled(6,850)83.14 
Adjustment due to Separation(13,830)53.72 
Nonvested at December 31, 2021— $— 
Restricted Stock Unit Activity
Restricted stock unit activity for the years ended December 31, 2022 and 2021 is set forth below:
Number of
Shares
Weighted-Average
Grant-Date
Fair Value (1)
Weighted-Average
Remaining
Contractual
Life (in Years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2021— $— 
Exchanged in Separation125,841 47.15 
Granted887,431 51.22 
Vested— — 
Canceled(175)57.15 
Outstanding at December 31, 20211,013,097 $50.71   
Granted259,545 57.61 
Vested(165,494)54.72   
Canceled(24,697)56.20   
Outstanding at December 31, 20221,082,451 $51.63 3.9$58,192,566 
Vested and expected to vest at December 31, 2022710,764 $52.68 3.3$38,210,673 
(1) The Company revised the grant date fair value of certain awards which were inaccurately disclosed related to the prior period. The Company determined that the update of this disclosure did not have a material impact to the current or prior period financial statements.
The restricted stock unit activity attributable to Consensus employees for the years ended December 31, 2021 and 2020 is set forth below:
Number of SharesWeighted-Average Remaining Contractual Life (in Years)Aggregate Intrinsic Value
Outstanding at January 1, 202010,357 
Granted5,431 
Vested(1,734)
Canceled(360)
Outstanding at December 31, 202013,694 
Granted4,416 
Vested(2,470)
Canceled(8,856)
Adjustment due to Separation(6,784)
Outstanding at December 31, 2021— 0.0$— 
Vested and expected to vest at December 31, 2021— 0.0$— 
Valuation Assumptions of Purchase Plan
The compensation expense related to the Purchase Plan has been estimated utilizing the following assumptions:
December 31, 2022December 31, 2021
Risk-free interest rate4.54%0.05%
Expected term (in years)0.50.5
Dividend yield0.00%0.00%
Expected volatility48.19%17.89%
Weighted average volatility48.19%17.89%
Stock Options Activity
The stock option activity attributable to Consensus employees for the years ended December, 2021 and 2020 is summarized as follows:
Number of Shares
Weighted-Average Exercise Price
Weighted-Average Remaining Contractual Life (In Years)
Intrinsic Value
Options outstanding at January 1, 20208,710 $29.53 
Granted
— 
Exercised
(250)$29.53 
Canceled
— 
Options outstanding at December 31, 20208,460 $29.53 
Granted
— 
Exercised
(250)29.53
Canceled
— 
Adjustment due to Separation(8,210)
Options outstanding at December 31, 2021— $— 0.0$— 
Exercisable at December 31, 2021— $— 0.0$— 
Vested and expected to vest at December 31, 2021— $— 0.0$—